Highlights
Institutional investors and hedge funds have adjusted their positions in Charles River Laboratories International, Inc., reflecting changes in holdings.
Several firms, including V Square Quantitative Management LLC, Versant Capital Management Inc, and Pinnacle Bancorp Inc, have reported increases in their stakes.
A significant percentage of the company’s stock is held by institutional investors.
Institutional Holdings and Recent Changes
V Square Quantitative Management LLC expanded its stake in Charles River Laboratories International, Inc. (NYSE:CRL) by over ten percent during the fourth quarter. The firm now holds more than a thousand shares of the medical research company’s stock, reflecting an increase from the prior reporting period.
Other financial institutions have also made adjustments to their positions. Versant Capital Management Inc increased its holdings significantly, reflecting a substantial rise in its ownership percentage. The firm now holds over a hundred shares after acquiring additional shares in the last quarter.
Additional Institutional Investments
Assetmark Inc. made a notable change in its holdings by adding a considerable number of shares to its portfolio during the third quarter. The firm now maintains a position in the company, indicating ongoing adjustments among financial institutions.
Similarly, Pinnacle Bancorp Inc. also expanded its position, with its latest filings showing a considerable increase in its stake. The firm added new shares, further contributing to the institutional ownership of the company.
Wilmington Savings Fund Society FSB entered a new position in the company, securing a stake during the third quarter. Another addition to the list of new institutional stakeholders is ORG Wealth Partners LLC, which also reported an initial investment in the medical research company during the fourth quarter.
Institutional Ownership Percentage
A vast majority of the company’s stock is currently held by institutional investors, with the latest figures indicating nearly full institutional ownership. The continuous adjustments by various firms reflect ongoing movements in holdings within the sector. The changes in ownership among these firms highlight shifts in institutional engagement with Charles River Laboratories International.
The company operates in the medical research sector, providing essential services that support pharmaceutical and biotechnology companies in their research and development efforts. The adjustments in institutional holdings may indicate strategic positioning among firms in response to the company’s market presence.